Courtesy of Benzinga.
Enzo Biochem, Inc. (NYSE: ENZ) (the “Company”), along with its subsidiary Enzo Life Sciences, Inc. entered into a Settlement with Affymetrix, Inc. (NASDAQ: AFFX) with respect to actions between the Company and Affymetrix before the U.S. District Court, Southern District of New York, Cases No 03-CV-8907 and 04-CV-1555.
As a result of the Agreement in settlement of the aforementioned cases, Affymetrix will pay $5,100,000. Enzo’s release of Affymetrix, Inc. does not include the litigation currently pending against Affymetrix, Inc. in the District of Delaware and any of the claims there asserted.
Posted-In: News Legal Press Releases
